The Trump administration decided to put the pilot on hold until at least 2027.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
CMS pauses weight-loss BALANCE model for Medicare Part D after insufficient plan sponsor participation, while Medicaid pilot continues.
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Trump administration is requiring all 50 states to explain their plans to revalidate some Medicaid providers. Dr.
The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...
The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
Can CMS put cannabinoids into Medicare for reimbursement without FDA approval, without safety analysis, and without public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results